
Please try another search
By Sam Boughedda
Investing.com -- Bio-Rad Laboratories Inc (NYSE:BIO), the life science and clinical diagnostic products firm gave an optimistic forecast at its investor day on Friday, boosting its shares by more than 7%.
The company released a statement soon after the event outlining its targets.
During its 2017 investor day, the company said it was targeting revenue growth of 3% to 5% and an adjusted earnings before interest, taxes, depreciation and amortization margin target of 20% + in 2020, which it exceeded.
Outlining its aims for 2025, the company is targeting approximately 9% core revenue CAGR from 2021 to 2025 and a 28% adjusted Ebitda margin in 2025.
“Having exceeded all of the long-term financial targets we outlined in 2017, we are now excited to share the details of our growth strategy and how we are poised to enhance our financial profile even further," said Norman Schwartz, Bio-Rad’s CEO.
"We are also introducing new products and capabilities, with an expanded suite of ddPCRTM products, initial offerings in single cell analysis, and molecular diagnostics,” he added.
During the investor day, the company spoke further on goals such as accelerating revenue growth through portfolio transformation, optimizing cost structure, and deploying capital for strategic acquisitions.
While Bio-Rad's shares have made substantial gains Friday, they are down 15% so far in 2022.
(Reuters) - Britain's antitrust watchdog said on Wednesday it has started an investigation into Amazon.com Inc (NASDAQ:AMZN) on concerns the U.S tech giant's practices affecting...
FRANKFURT (Reuters) - Frankfurt Airport, Germany's busiest air transport hub, is unlikely to see relief for a crippling staff shortage in the coming months, its operator Fraport...
By Toby Sterling (Reuters) - Amazon (NASDAQ:AMZN) has agreed to take a 2% stake in Just Eat Takeaway.com's struggling U.S. meal delivery business Grubhub and will offer its Prime...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.